Cargando…

Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

BACKGROUND: Identification of novel biomarker is important for development of molecular-targeted therapy agents for patients with hepatocellular carcinoma (HCC). This study aims to identify potential prognostic biomarkers and investigate epigenetic mechanism of HCC development. METHODS: Public bulk-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Zengwei, Yang, Yuan, Chen, Wen, Li, Enliang, Liang, Tingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800332/ https://www.ncbi.nlm.nih.gov/pubmed/35093119 http://dx.doi.org/10.1186/s12967-022-03249-2

Ejemplares similares

Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2022)

NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma
por: Luo, Xiaoling, et al.
Publicado: (2017)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation
por: Bian, Xinyu, et al.
Publicado: (2021)

Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2023)

Correction: Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2023)

Evaluation of Oncogene NUP37 as a Potential Novel Biomarker in Breast Cancer
por: Li, Kangdi, et al.
Publicado: (2021)

miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy
por: Chen, Enjiang, et al.
Publicado: (2021)

Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2021)

Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma
por: He, Ya, et al.
Publicado: (2022)

Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma
por: Li, Hong-Tao, et al.
Publicado: (2020)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
por: Zhuang, Liping, et al.
Publicado: (2018)

Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2018)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022)

Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement
por: Huang, Xing, et al.
Publicado: (2020)

HOXA repression is mediated by nucleoporin Nup93 assisted by its interactors Nup188 and Nup205
por: Labade, Ajay S., et al.
Publicado: (2016)

LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression
por: Wu, Rongshou, et al.
Publicado: (2023)

Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling
por: Tang, Zengwei, et al.
Publicado: (2023)

Ordered Regions of Channel Nucleoporins Nup62, Nup54, and Nup58 Form Dynamic Complexes in Solution
por: Sharma, Alok, et al.
Publicado: (2015)

Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
por: Li, Bin-Kui, et al.
Publicado: (2014)

Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma
por: Tan, Xiaolong, et al.
Publicado: (2018)

Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma
por: Feng, Ying, et al.
Publicado: (2018)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients
por: Zhang, Qian, et al.
Publicado: (2015)

VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017)

Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma
por: Yang, Huiqiong, et al.
Publicado: (2018)

The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Hao, et al.
Publicado: (2019)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Dongyu, et al.
Publicado: (2021)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2018)

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Li, Jing, et al.
Publicado: (2022)

MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma
por: Kobayashi, Go, et al.
Publicado: (2023)

Uncleavable Nup98–Nup96 is functional in the fission yeast Schizosaccharomyces pombe
por: Asakawa, Haruhiko, et al.
Publicado: (2015)

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
por: Zhou, Xin, et al.
Publicado: (2022)

High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma
por: Shao, Mingrui, et al.
Publicado: (2021)

MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression
por: Liu, Zhikun, et al.
Publicado: (2018)

Scaffold nucleoporins Nup188 and Nup192 share structural and functional properties with nuclear transport receptors
por: Andersen, Kasper R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mnn6umrdve3vd5lfqbn1qr38fp